Pharmacogenomics and lung transplantation: clinical implications.
Burckart, G J
Pharmacogenomics and lung transplantation: clinical implications. [electronic resource] - The pharmacogenomics journal - 301-10 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1470-269X
10.1038/sj.tpj.6500376 doi
ATP Binding Cassette Transporter, Subfamily B
ATP Binding Cassette Transporter, Subfamily B, Member 1
Algorithms
Biological Availability
Biomarkers--blood
Cytochrome P-450 CYP3A
Cytochrome P-450 Enzyme System--genetics
Drug Monitoring
Drug Resistance
Gene Expression Profiling
Graft Rejection--blood
Heart Transplantation
Humans
Immunosuppressive Agents--adverse effects
Lung Transplantation
Organic Anion Transporters--genetics
Pharmacogenetics
Polymorphism, Genetic
Practice Guidelines as Topic
Tacrolimus--adverse effects
Treatment Outcome
Pharmacogenomics and lung transplantation: clinical implications. [electronic resource] - The pharmacogenomics journal - 301-10 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1470-269X
10.1038/sj.tpj.6500376 doi
ATP Binding Cassette Transporter, Subfamily B
ATP Binding Cassette Transporter, Subfamily B, Member 1
Algorithms
Biological Availability
Biomarkers--blood
Cytochrome P-450 CYP3A
Cytochrome P-450 Enzyme System--genetics
Drug Monitoring
Drug Resistance
Gene Expression Profiling
Graft Rejection--blood
Heart Transplantation
Humans
Immunosuppressive Agents--adverse effects
Lung Transplantation
Organic Anion Transporters--genetics
Pharmacogenetics
Polymorphism, Genetic
Practice Guidelines as Topic
Tacrolimus--adverse effects
Treatment Outcome